What Are the Doses for Ozempic for Weight Loss?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide for weight loss follows a carefully structured dosing protocol that begins at a low starting point and progresses upward based on individual tolerance and results. The medication activates GLP-1 receptors in the brain to reduce hunger and increase satiety, with clinical trials showing average weight loss of 10-15% of body weight over six months. Understanding how dosing works helps patients set realistic expectations and work effectively with their healthcare provider.

How Semaglutide Dosing Typically Begins

The standard semaglutide weight loss protocol starts at 0.25 mg once weekly, a dose designed to allow your body to adapt to the medication while minimizing side effects. This opening dose is significantly lower than the effective therapeutic range because the goal is tolerability first, efficacy second. Most patients tolerate this initial dose without severe nausea or other gastrointestinal symptoms.

Your first injection marks the beginning of a four-week observation period where PlexusDx and your medical team monitor how your body responds. During this window, you'll track your appetite changes, energy levels, and any side effects. This baseline data informs whether you're ready to move forward in the dosing progression or whether an additional week at the starting dose makes sense for your situation.

The Weekly Dose Escalation Schedule

After week four, semaglutide dosing typically increases to 0.5 mg weekly, then progresses through 1.0 mg, 1.7 mg, and finally 2.4 mg at weekly intervals. Each step-up occurs once every seven days, meaning the full progression from start to maximum dose spans approximately 16 weeks. This gradual titration allows your GLP-1 receptors to develop sensitivity to the medication without overwhelming your system.

Not every patient reaches the 2.4 mg maximum dose—some achieve meaningful weight loss and improved appetite control at intermediate doses like 1.0 or 1.7 mg. Your individual response, side effect tolerance, and weight loss progress determine where your optimal maintenance dose sits. PlexusDx works with prescribers to customize this timeline based on your unique physiology and goals rather than forcing all patients into an identical schedule.

Maintenance Dosing and Long-Term Management

Once you reach a dose producing consistent weight loss and appetite suppression with tolerable side effects, that becomes your maintenance dose—the amount you continue weekly unless clinical circumstances change. Maintenance doses range from 0.5 mg to 2.4 mg depending on individual response, and staying at the same weekly dose indefinitely is medically appropriate if results remain steady. The goal is finding the lowest effective dose that delivers results without unnecessary side effects.

Throughout your treatment journey, periodic check-ins with your PlexusDx medical team assess whether dose adjustments are warranted. If weight loss plateaus after three months, a modest increase might restart progress. If side effects intensify, a slight reduction could restore tolerability. This dynamic approach differs from rigid protocols that ignore individual variation and reinforces PlexusDx's personalized philosophy.

Why Genetic Testing Informs Your Semaglutide Dosing

The PlexusDx Precision Peptide Genetic Test examines genetic variants affecting how your body processes GLP-1 receptor signaling, including the GLP1R rs6923761 marker that influences receptor sensitivity. Patients with certain genetic predispositions may achieve effective results at lower doses, while others might require higher doses to achieve comparable weight loss. This genetic insight helps your provider anticipate whether you'll be a 'responder' at standard doses or need personalization.

Additional genetic markers like FTO rs9939609 and MC4R rs17782313 reveal how your body regulates appetite and fat storage independent of GLP-1 activity. When PlexusDx integrates this genetic data with your clinical response during titration, your prescriber gains confidence that your maintenance dose aligns with your biology rather than a population average. This precision reduces trial-and-error dosing and accelerates the path to meaningful results.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

Semaglutide weight loss treatment begins at 0.25 mg as a single weekly injection, the lowest marketed dose designed for tolerability during your first month. After four weeks, the dose typically increases by 0.25 mg increments weekly until reaching an optimal maintenance dose. PlexusDx monitors your response at each step to ensure safe, effective progression.

How long does it take to reach the full 2.4 mg dose?

The standard titration schedule spans approximately 16 weeks from 0.25 mg to the 2.4 mg maximum, advancing 0.25 mg each week. However, not all patients need to reach 2.4 mg—many achieve their weight loss goals at 1.0 mg or 1.7 mg. Your PlexusDx provider customizes this timeline based on your response and tolerance.

Does PlexusDx charge more if I increase my semaglutide dose?

No—PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and remains flat across all dose levels. Your dose may need to go up. Your price won't. HSA and FSA accounts are eligible, and no insurance or membership is required.

What happens if I experience side effects at my current dose?

If nausea, vomiting, or other side effects become bothersome, your PlexusDx medical team can reduce your dose slightly or extend the time between titration steps. Most side effects improve as your body adapts within 1-2 weeks. Slower titration schedules often allow continued progress with better tolerability.

How does the Precision Peptide Genetic Test affect my semaglutide dosing?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.